Literature DB >> 9008468

Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats.

S Ishiyama1, M Hiroe, T Nishikawa, S Abe, T Shimojo, H Ito, S Ozasa, K Yamakawa, M Matsuzaki, M U Mohammed, H Nakazawa, T Kasajima, F Marumo.   

Abstract

BACKGROUND: Excess amounts of NO produced by an inducible NO synthase (iNOS) in response to cytokines may be cytotoxic and can be destructive to tissue. We investigated the role of NO in the development of myocardial damage and the effects of aminoguanidine (AG), an inhibitor of iNOS, on experimental autoimmune myocarditis in rats. METHODS AND
RESULTS: Autoimmune myocarditis was induced in 20 Lewis rats by injection of porcine cardiac myosin. Ten of the 20 rats were administered AG. The severity of myocarditis was evaluated by measuring the size of myocarditic lesion and serum levels of CK-MB. Serum NO levels were determined using the Cd/Cu method. Tissue specimens were immunohistochemically examined for iNOS and nitrotyrosine. Histopathological study revealed extensive myocardial destruction and massive inflammatory cell infiltration in AG-untreated rats but only focal mononuclear cell infiltration in AG-treated rats. The mean percent areas of inflammatory lesions in the untreated and treated rats were 56 +/- 13% and 3 +/- 2%, respectively (P < .001). NO levels were 102 +/- 23 and 25 +/- 9 IU/L, respectively (P < .01). CK-MB levels were 68 +/- 13 and 16 +/- 13 nmol/L, respectively (P < .01). Superoxide production as measured with an ex vivo monitoring system was also significantly decreased in the treated rats. Nitrotyrosine relating to the generation of peroxynitrite was detected through immunostaining in the inflammatory lesions of untreated rats but not in those of treated rats.
CONCLUSIONS: Excess amounts of NO produced by iNOS appear to contribute to the progression of myocardial damage in myocarditis. AG may prove to be useful in the treatment of myocarditis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9008468     DOI: 10.1161/01.cir.95.2.489

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Macrophage diversity in cardiac inflammation: a review.

Authors:  Jobert G Barin; Noel R Rose; Daniela Ciháková
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

Review 2.  Oxidative stress in heart failure: what are we missing?

Authors:  Douglas B Sawyer
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

3.  Transport of nitrated albumin across continuous vascular endothelium.

Authors:  Dan Predescu; Sanda Predescu; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

Review 4.  Diagnosis and management of pediatric myocarditis.

Authors:  Desmond Bohn; Lee Benson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management.

Authors:  M T Kearney; J M Cotton; P J Richardson; A M Shah
Journal:  Postgrad Med J       Date:  2001-01       Impact factor: 2.401

Review 6.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning.

Authors:  Péter Ferdinandy; Richard Schulz
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

7.  Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery.

Authors:  Miklos D Kertai; Yi-Ju Li; Yunqi Ji; Wenjing Qi; Frederick W Lombard; Svati H Shah; William E Kraus; Mark Stafford-Smith; Mark F Newman; Carmelo A Milano; Nathan Waldron; Mihai V Podgoreanu; Joseph P Mathew
Journal:  Am Heart J       Date:  2015-06-17       Impact factor: 4.749

Review 8.  An approach to the treatment of pediatric myocarditis.

Authors:  Daniel Levi; Juan Alejos
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Cardioprotective effects of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), a novel free radical scavenger, on acute autoimmune myocarditis in rats.

Authors:  Taka-Aki Okabe; Chiharu Kishimoto; Miki Hattori; Masaomi Nimata; Keisuke Shioji; Toru Kita
Journal:  Exp Clin Cardiol       Date:  2004

10.  Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.

Authors:  Masaomi Nimata; Chiharu Kishimoto; Zuyi Yuan; Keisuke Shioji
Journal:  Mol Cell Biochem       Date:  2004-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.